Breaking into established mature markets is a slow process. We should continue to pursue them but in the
meanwhile we should concentrate on China. From what I hear the Chinese surgeons are anxious to
use our patch since their patches are not world class. I doubt that they are using Uncle Sams material
so this is a golden opportunity for Admedus to take a lead in this massive market which might be easier to
crack as opposed to EU and the USA with all their hurdles. Get a Chinese partner and do a deal.
The number of annual patches for China could be in excess of 100,000
Welcome to the fourth quarter, page-50
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $14.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.25 | 328 | 1 |
View Market Depth
| Last trade - 09.39am 08/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable